|
|
|||||||
 |
|
|
LinkBack | Thread Tools | Display Modes |
04-22-2010, 06:10 PM
|
|||
|
|||
New Data Indicate Effectiveness Of Clarient's Pulmotax(TM) Test For Lung Cancer
Clarient, Inc. (Nasdaq: CLRT), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, announced that data from a new study suggest that the Clarient Insight Dx Pulmotax assay may effectively predict which lung cancer patients will respond favorably to chemotherapy. The study, titled "TLE3 expression is predictive of response to chemotherapy in ...
    
|
|
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| ZERO demands ACS apology on effectiveness of PSA test | cancerfr | Liver Cancer | 0 | 07-03-2010 09:44 AM |
| Clarient Insight Dx Pulmotax assay helps predict response to chemotherapy in lung can | cancerfr | Lung Cancer | 0 | 04-21-2010 09:55 PM |
| New Data Indicate Effectiveness of Clarient's Pulmotax(TM) Test for Lung Cancer | cancerfr | Lung Cancer | 0 | 04-21-2010 09:55 PM |
| Clinical Trial Test Helps Measure Effectiveness Of Treatment For Patients With Metast | cancerfr | Latest Cancer News | 0 | 04-02-2010 01:34 PM |
| Clinical Trial Test Helps Measure Effectiveness of Treatment for Patients with Metast | cancerfr | Gallbladder Cancer | 0 | 04-02-2010 05:14 AM |
Linear Mode
